(Allergan plc)

	AGN latest price $277.9672 (2%) ($265.4297 - $278.7104) on Fri. Oct. 2, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.52% (three month average)
RSI	46
Latest Price	$277.9672(2%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.7% a day on average for past five trading days.
Weekly Trend	AGN declines -5.1% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Value stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(53%)    IBB(52%)    XBI(46%)    ARKG(42%)    IWF(41%)
Factors Impacting AGN price	AGN will decline at least -1.26% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-8%)    SHY(-6%)    IGOV(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.26% (StdDev 2.52%)
Hourly BBV	0 ()
Intraday Trend	3.6%

1 - 5 Day Possible Target	$255.23(-8.18%)
5 Day Moving Average	$260.43(6.73%)
10 Day Moving Average	$267.95(3.74%)
20 Day Moving Average	$277.22(0.27%)
To recent high	-15.2%
To recent low	14.2%
Market Cap	$91.646b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed